Sex differences in the therapy of kidney and ureteral stones.


Journal

Current opinion in urology
ISSN: 1473-6586
Titre abrégé: Curr Opin Urol
Pays: United States
ID NLM: 9200621

Informations de publication

Date de publication:
05 2019
Historique:
pubmed: 12 3 2019
medline: 10 3 2020
entrez: 12 3 2019
Statut: ppublish

Résumé

Better understanding of sex differences affecting urolithiasis may help us offer tailored treatment strategies to our patients. The incidence of urolithiasis is increasing and the male-to-female ratio has decreased from 3 : 1 to 1.3 : 1 between 1970 and 2000. In women, obesity has a larger effect on the risk of developing urolithiasis [odds ratio (OR) 1.35; 95% confidence interval (CI): 1.33-1.37] compared with men (OR 1.04; 95% CI: 1.02-1.06). Urolithiasis is a risk factor for coronary artery disease in men (risk ratio = 1.23; 95% CI: 1.02-1.49) and for stroke in women (risk ratio = 1.12; 95% CI: 1.03-1.21). Women tolerate cystoscopic stent removal and shock wave lithotripsy better than men. For shock wave lithotripsy menopaused women have reported lower visual analog scale scores than menstruating women (P < 0.001). Female sex was an independent predictor of stone impaction (OR 1.15; 95% CI: 1.03-1.27) and postoperative sepsis after ureteroscopy (OR 2.31; 95% CI: 1.14-4.37). The sex gap in urolithiasis is closing. The changing role of women in society and dietary habits can be responsible for this epidemiologic shift. Women show a higher threshold for pain during urologic procedures, but they suffer from infectious complications more than men. Urolithiasis is a risk factor for cardiovascular events in both sexes.

Identifiants

pubmed: 30855373
doi: 10.1097/MOU.0000000000000604
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

261-266

Auteurs

Mehmet Özsoy (M)

Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna General Hospital.
Urology and Andrology, Karl Landsteiner Society, Vienna, Austria.

Bhaskar Somani (B)

University Hospital Southampton NHS Trust.
University of Southampton, Southampton, UK.

Christian Seitz (C)

Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna General Hospital.

Julian Veser (J)

Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna General Hospital.

Panagiotis Kallidonis (P)

Department of Urology, University of Patras, Patras, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH